Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
| ▸ | CTSS | P25774 | 1/20 | 0.42 |
| ▸ | SYK | P43405 | 1/20 | 0.41 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.41 |
| ▸ | CDK2 | P24941 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8897257 | 1.00 | LMNA (0.46) | LMNASMN1; SMN2MAPK1HTTTP53 | |
| SCHEMBL11294755 | 1.00 | LMNA (0.46) | LMNASMN1; SMN2MAPK1HTTTP53 | |
| SCHEMBL3462691 | 0.88 | LMNA (0.50) | LMNASMN1; SMN2HTTGAAMAPT | |
| SCHEMBL2138925 | 0.88 | LMNA (0.50) | LMNASMN1; SMN2HTTGAAMAPT | |
| SCHEMBL11291906 | 0.88 | LMNA (0.50) | LMNASMN1; SMN2HTTGAAMAPT | |
| SCHEMBL11146434 | 0.86 | ALDH1A1 (0.45) | LMNASMN1; SMN2HTTGAAMAPT | |
| SCHEMBL11294170 | 0.86 | HTT (0.52) | LMNASMN1; SMN2HTTGAAFOLH1 | |
| SCHEMBL11048769 | 0.86 | HTT (0.52) | LMNASMN1; SMN2HTTGAAFOLH1 | |
| SCHEMBL11310616 | 0.86 | HTT (0.52) | LMNASMN1; SMN2HTTGAAFOLH1 | |
| SCHEMBL11310220 | 0.84 | LMNA (0.47) | LMNASMN1; SMN2MAPK1HTTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4136254-A | PROCESS OF SELECTIVELY BLOCKING AMINO FUNCTIONS IN AMINOGLYCOSIDES USING TRANSITION METAL SALTS AND INTERMEDIATES USED THEREBY | SCHERING CORPORATION (US) | 1979-01-23 | — | — | US | claimed |
| EP-0547031-B1 | N-protected-(S)-isoserine compounds | SCHERING CORP (US) | 1997-04-23 | — | — | EP | disclosed |
| US-5539121-A | 2-formylmercaptobenzothiazole | SCHERING CORPORATION (US) | 1996-07-23 | — | — | US | disclosed |
| US-5442047-A | Process for preparing isepamicin | SCHERING CORPORATION (US) | 1995-08-15 | — | — | US | disclosed |
| EP-0405820-B1 | Improved process for preparing isepamicin | SCHERING CORP (US) | 1994-04-13 | — | — | EP | disclosed |
| EP-0547031-A1 | N-protected-(S)-isoserine compounds | SCHERING CORPORATION (US) | 1993-06-16 | — | — | EP | disclosed |
| EP-0478707-A1 | IMPROVED PROCESS FOR PREPARING ISEPAMICIN | SCHERING CORPORATION (US) | 1992-04-08 | — | — | EP | disclosed |
| EP-0405820-A2 | Improved process for preparing isepamicin | SCHERING CORPORATION (US) | 1991-01-02 | — | — | EP | disclosed |
| WO-1990015810-A2 | IMPROVED PROCESS FOR PREPARING ISEPAMICIN | SCHERING CORPORATION (US) | 1990-12-27 | — | — | WO | disclosed |
| EP-0185323-B1 | 2',3'-DIDEOXY-2'-FLUOROKANAMYCIN A AND 1-N-(ALPHA-HYDROXY-OMEGA-AMINOALKANOYL) DERIVATIVES THEREOF | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1988-08-24 | — | — | EP | disclosed |
| EP-0139553-A2 | 1N-(omega-amino-alpha-hydroxyalkanoyl)-2',3'-dideoxykanamycin A and the production of the same | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1985-05-02 | — | — | EP | disclosed |
| US-4424343-A | Preparation of 1-N- ω-amino-α-hydroxyalkanoyl!kanamycin polysilylates and products | BRISTOL MYERS COMPANY (US) | 1984-01-03 | — | — | US | disclosed |
| US-4337335-A | Transition metal salt complexes of polyamino organic compounds | SCHERING CORPORATION (US) | 1982-06-29 | — | — | US | disclosed |
| US-4231945-A | BACTERICIDES | SCHERING CORPORATION (US) | 1980-11-04 | — | — | US | disclosed |
| US-4230847-A | Aminoglycoside antibiotic compounds | SCHERING CORPORATION (US) | 1980-10-28 | — | — | US | disclosed |
| US-4212859-A | OXIMINATION OF AMINO PRECURSOR, ACID HYDROLYSIS, REDUCTION OF OXO GROUP | SCHERING CORPORATION (US) | 1980-07-15 | — | — | US | disclosed |
| US-4212860-A | COUPLING THE PENTOFURANOSYL ONTO THE PROTECTED CYCLITOL | SCHERING CORPORATION (US) | 1980-07-15 | — | — | US | disclosed |
| EP-0000473-A1 | Process for preparing aminoglycoside derivatives, novel derivatives obtained and pharmaceutical compositions containing such derivatives | Technobiotic Ltd. (CH) | 1979-02-07 | — | — | EP | disclosed |
| US-4136254-A | PROCESS OF SELECTIVELY BLOCKING AMINO FUNCTIONS IN AMINOGLYCOSIDES USING TRANSITION METAL SALTS AND INTERMEDIATES USED THEREBY | SCHERING CORPORATION (US) | 1979-01-23 | — | — | US | disclosed |
| US-4053591-A | 5-DEOXY-4,6-DI-O-(AMINOGLYCOSYL)-1,3-DIAMINOCYCLITOLS, METHODS FOR THEIR MANUFACTURE, METHOD FOR THEIR USE AS ANTIBACTERIAL AGENTS AND COMPOSITIONS USEFUL THEREFOR | SCHERING CORPORATION (US) | 1977-10-11 | — | — | US | disclosed |